XJ International Holdings Co., Ltd.

SEHK:1765 Stock Report

Market Cap: HK$1.1b

XJ International Holdings Valuation

Is 1765 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1765 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 1765's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 1765's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1765?

Key metric: As 1765 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 1765. This is calculated by dividing 1765's market cap by their current revenue.
What is 1765's PS Ratio?
PS Ratio0.3x
SalesCN¥3.69b
Market CapCN¥1.06b

Price to Sales Ratio vs Peers

How does 1765's PS Ratio compare to its peers?

The above table shows the PS ratio for 1765 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.3x
1082 Bradaverse Education (Int'l) Investments Group
8.2xn/aHK$997.2m
1525 Shanghai Gench Education Group
1.2xn/aHK$1.2b
1593 Chen Lin Education Group Holdings
2.4xn/aHK$1.4b
1935 JH Educational Technology
1.3xn/aHK$1.3b
1765 XJ International Holdings
0.3xn/aHK$1.1b

Price-To-Sales vs Peers: 1765 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (3.3x).


Price to Sales Ratio vs Industry

How does 1765's PS Ratio compare vs other companies in the HK Consumer Services Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
2138 EC Healthcare
0.2x6.0%US$106.60m
1739 Qeeka Home (Cayman)
0.2xn/aUS$30.46m
8181 Shi Shi Services
0.2xn/aUS$17.70m
919 Modern Healthcare Technology Holdings
0.2xn/aUS$10.46m
1765 0.3xIndustry Avg. 1.2xNo. of Companies11PS012345+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 1765 is good value based on its Price-To-Sales Ratio (0.3x) compared to the Hong Kong Consumer Services industry average (1.2x).


Price to Sales Ratio vs Fair Ratio

What is 1765's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1765 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 1765's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1765 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$0.14
HK$0.65
+368.9%
23.0%HK$0.80HK$0.50n/a2
Nov ’25HK$0.16
HK$0.65
+304.4%
23.0%HK$0.80HK$0.50n/a2
Oct ’25HK$0.17
HK$0.65
+289.8%
23.0%HK$0.80HK$0.50n/a2
Sep ’25HK$0.21
HK$0.65
+212.6%
23.0%HK$0.80HK$0.50n/a2
Aug ’25HK$0.20
HK$0.65
+215.6%
23.0%HK$0.80HK$0.50n/a2
Jul ’25HK$0.18
HK$0.73
+302.3%
18.2%HK$0.82HK$0.50n/a4
Jun ’25HK$0.23
HK$0.73
+217.0%
18.4%HK$0.82HK$0.50n/a4
May ’25HK$0.24
HK$0.73
+205.0%
18.4%HK$0.82HK$0.50n/a4
Apr ’25HK$0.25
HK$0.72
+191.6%
18.0%HK$0.83HK$0.50n/a4
Mar ’25HK$0.34
HK$0.72
+111.8%
18.0%HK$0.83HK$0.50n/a4
Feb ’25HK$0.30
HK$0.72
+136.5%
18.1%HK$0.83HK$0.50n/a4
Jan ’25HK$0.36
HK$0.72
+100.3%
18.1%HK$0.83HK$0.50n/a4
Dec ’24HK$0.41
HK$0.68
+63.6%
11.2%HK$0.75HK$0.59n/a4
Nov ’24HK$0.45
HK$0.68
+50.9%
11.2%HK$0.75HK$0.59HK$0.164
Oct ’24HK$0.49
HK$0.68
+37.2%
11.2%HK$0.75HK$0.59HK$0.174
Sep ’24HK$0.51
HK$0.69
+36.1%
10.2%HK$0.76HK$0.60HK$0.215
Aug ’24HK$0.57
HK$0.71
+24.1%
11.1%HK$0.79HK$0.61HK$0.205
Jul ’24HK$0.52
HK$0.71
+36.0%
11.1%HK$0.79HK$0.61HK$0.185
Jun ’24HK$0.56
HK$0.71
+26.3%
11.1%HK$0.79HK$0.61HK$0.235
May ’24HK$0.60
HK$0.68
+13.8%
13.3%HK$0.80HK$0.54HK$0.245
Apr ’24HK$0.62
HK$0.71
+14.7%
16.8%HK$0.90HK$0.55HK$0.255
Mar ’24HK$0.69
HK$0.96
+39.4%
55.6%HK$2.13HK$0.56HK$0.346
Feb ’24HK$0.80
HK$0.96
+20.2%
55.6%HK$2.13HK$0.56HK$0.306
Jan ’24HK$0.70
HK$0.89
+27.2%
55.1%HK$2.07HK$0.54HK$0.367
Dec ’23HK$0.68
HK$1.01
+48.0%
50.6%HK$2.04HK$0.48HK$0.416
Nov ’23HK$0.51
HK$1.00
+95.2%
41.1%HK$1.87HK$0.48HK$0.458

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies